🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Recent changes in the mutational dynamics of the SARS-CoV-2 main-protease substantiate the danger of emerging resistance to antiviral drugs. #covid researchsquare.com/article/rs-185…

Out latest publication in Scientific Reports is online! We are excited to share the details on how we use our Catalophore Halo technology to rapidly track changes in the RBD/hACE2 interface. Enjoy the short video summary and visit rdcu.be/cUn8E to read the full text. #COVID19

Using a structural bioinformatics approach, researchers from Innophore, Uni Graz/University of Graz and Amazon Web Services predict that Omicron spike receptor binding domain has a higher affinity to human ACE2 receptors, when compared to the wild type reference. nature.com/articles/s4159…

Grazer ForscherInnen entwickeln Technologie zur präzisen Einschätzung der Gefährlichkeit von Virus-Varianten 🔗 news.uni-graz.at/de/detail/arti… #weworkfortomorrow 📷 Innophore, Verena Resch #acib

Grazer und Wiener Wissenschafter entwickeln eine Technologie, mit der sie die Mutation von Viren beobachten und voraussagen wollen. dlvr.it/SYJPwb

Scientific publications often just report the hard facts, leaving out the story on what lead to the final findings. Take a look behind the scenes of one of our most recent publications and learn more about its creation in our blog post at Nature Portfolio. go.nature.com/3NebrBk

The innophore teams CavitOmiX for your #PyMol cavities #StructuralBiology @[email protected] #proteinstructureandfunction #enzymeengineering pymolwiki.org/index.php/Cavi…

#Antiviral drugs are one of the first lines of defense in fighting viral diseases. But is there a link between antiviral drugs and the evolution of the virus? Let's find out and read our recent publication here ⬇️ frontiersin.org/articles/10.33… #SARSCoV2 #mutations

Behind the paper at Nature Portfolio on designing variant-specific therapeutic SARS-CoV-2 decoys. The workflow features our #Catalophore™ Halos, deep #neuralnetworks and MD #simulations plus experimental validation. Read the full post here: go.nature.com/3QO7SUk

Inspiring talks by A. Pritzel from @DeepMind and B. Nestl from Innophore about the potencial of AI in Biocatalysis #Biotrans2023 HetBiocat

Our COO, Bettina Nestl, will attend Bio-Europe Spring 2024 in Barcelona next week. Excited to connect and share insights on enzyme discovery, drug repurposing, and side-effect prediction! #BioEurope2024 #biotech #Biopharma #Innophore

Discover AI's impact on drug discovery with GPU-powered BioNeMo at #GTC24. On Mar 20, at 10am CET, learn how NVIDIA and Innophore innovate protein design, analyze biomolecular data, and apply insights through case studies in therapeutic breakthroughs. nvda.ws/4cebHfL